建模新冠疫苗加强针诱导的抗体反应及感染史的影响
研究监测医护人员抗受体结合域(RBD)IgG抗体,扩展数学模型拟合有无既往SARS-CoV-2感染时加强接种后的抗体滴度。模型显示无论有无感染史,加强接种后抗RBD IgG滴度升高程度相当,但感染史使抗体反应持续时间延长1.28倍。该定量方法可基于个体免疫史为未来疫苗接种策略提供依据。
要点
- 加强接种后抗RBD IgG滴度升高程度在有无感染史者间相当。
- 既往SARS-CoV-2感染使抗体反应持续时间延长1.28倍。
- 数学模型可基于个体免疫史为未来疫苗接种策略提供依据。
核心结论
- 加强接种后抗RBD IgG滴度升高程度在有无感染史者间相当,但感染史使抗体反应持续时间延长1.28倍。
研究设计与样本
- 研究监测医护人员抗RBD IgG抗体的纵向数据,扩展既往开发的数学模型拟合有无既往SARS-CoV-2感染时加强接种后的抗体滴度随时间变化。
主要发现
- 数学模型定量分析表明,无论有无感染史,加强接种后抗RBD IgG滴度升高程度相当。
- 既往感染史使抗体反应持续时间延长1.28倍。
临床怎么用
- 作者认为该数学建模方法可基于个体免疫史为未来疫苗接种策略提供依据。
- 作者认为该简单定量方法可扩展至任何类型的疫苗接种,从而为未来大流行中分配加强疫苗以增强免疫力的政策决策提供基础。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The 3-dose COVID-19 vaccine (booster vaccination) has been offered worldwide. As booster vaccinations continue, it is important to understand the antibody dynamics elicited by booster vaccination in order to evaluate and develop vaccination needs and strategies. Here, we investigated longitudinal data by monitoring IgG antibodies against the receptor binding domain (RBD) in health care workers. We extended our previously developed mathematical model to booster vaccines and successfully fitted antibody titers over time in the absence and presence of past SARS-CoV-2 infection. Quantitative analysis using our mathematical model indicated that anti-RBD IgG titers increase to a comparable extent after booster vaccination, regardless of the presence or absence of infection, but infection history extends the duration of antibody response by 1.28 times. Such a mathematical modeling approach can be used to inform future vaccination strategies on the basis of an individual's immune history. Our simple quantitative approach can be extended to any kind of vaccination and therefore can form a basis for policy decisions regarding the distribution of booster vaccines to strengthen immunity in future pandemics.
引用
- Nishiyama T, Miyamatsu Y, Park H, et al. Modeling COVID-19 vaccine booster-elicited antibody response and impact of infection history. Vaccine. 2023. PMID: 38008663. doi:10.1016/j.vaccine.2023.11.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。